Market Overview

My goal is to be on stage with my computer and let you
see my screen and make sure you know what buttons to
press, where you’re getting in & out, how to calculate
risk, your targets — all of those things.
It’s real-life trading. Make sure you sign up!
- Jerremy Newsome

Q4 Earnings Outlook For OrthoPediatrics


On Wednesday, Mar. 6, OrthoPediatrics (NASDAQ: KIDS) will release its latest earnings report. Here is Benzinga's outlook for the company based on it's announcement.

Earnings and Revenue

OrthoPediatrics EPS loss is expected to be around 19 cents, according to sell-side analysts. Sales will likely be near $14.22 million.

In the same quarter last year, OrthoPediatrics reported a loss per share of $4.35 on revenue of $11 million. Revenue would be up 21.74 percent from the same quarter last year. Here's how the company's EPS has stacked up against analyst estimates in the past:


Quarter Q3 2018 Q2 2018 Q1 2018 Q4 2017
EPS Estimate -0.11 -0.14 -0.3 -0.17
EPS Actual -0.15 -0.21 -0.41 -4.35

Stock Performance

Over the last 52-week period, shares are up 149.65 percent. Given that these returns are generally positive, long-term shareholders should be satisfied going into this earnings release. Over the past 90 days, analysts have adjusted their estimates higher for EPS and revenues. Analysts generally rate OrthoPediatrics stock as Neutral. The strength of this rating has dwindled over the past three months.

Posted-In: Earnings News


Related Articles (KIDS)

View Comments and Join the Discussion!

Alto, An Alternative Investment Platform For IRAs, Raises $2.8M

Q4 Earnings Outlook For Yext